Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy

We have reported that sulforaphane (SFN) prevented diabetic cardiomyopathy in both type 1 and type 2 diabetes (T2DM) animal models via the upregulation of nuclear transcription factor erythroid 2–related factor 2 (Nrf2) and metallothionein (MT). In this study, we tested whether SFN protects the hear...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes
Egile Nagusiak: Gu, Junlian, Cheng, Yanli, Wu, Hao, Kong, Lili, Wang, Shudong, Xu, Zheng, Zhang, Zhiguo, Tan, Yi, Keller, Bradley B., Zhou, Honglan, Wang, Yuehui, Xu, Zhonggao, Cai, Lu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2017
Gaiak:
Complications
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248986/
https://ncbi.nlm.nih.gov/pubmed/27903744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db15-1274
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak